Moderna reports positive data from personalized cancer vaccine trials
Overall, the vaccine was well tolerated by the patients, with any adverse effects typically being low grade and reversible.
FILE PHOTO: A sign marks the headquarters of Moderna Therapeutics, which is developing a vaccine against the coronavirus disease (COVID-19), in Cambridge, Massachusetts, U.S., May 18, 2020(photo credit: BRIAN SNYDER/REUTERS)ByAARON REICH
